ADEBISI OSHO-OKUNNUBI: Open Payments
NPI 1194243592 · PERTH AMBOY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 25 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $47 · 2025 $646
Food & beverage: $469Education: $177
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 2 | $125 |
| Gilead Sciences, Inc. | 2 | $92 |
| Janssen Biotech, Inc. | 3 | $57 |
| Caris MPI, Inc. | 1 | $36 |
| Novocure Inc. | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| UCB, Inc. | 1 | $24 |
| GENZYME CORPORATION | 1 | $23 |
| Genmab U.S., Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: FOTIVDA, Trodelvy, MI CANCER SEEK, Venclexta, Optune Lua (NovoTTF-200T), MONOFERRIC, Bimzelx, CEREZYME.
Industry payments across NJ — which companies pay providers there.
